Early detection and personalized approaches to cancer prevention, treatment and survivorship are increasingly at the center of oncology care. As genetic testing becomes more commonly integrated into this space, proactive oncology has also come to encompass earlier and more precise identification of hereditary cancer risk and strategies for managing that risk over time. In many patient encounters, these discussions still tend to focus on the genetic risk itself without necessarily extending into the broader social, structural and environmental contexts that influence how that risk is understood and lived. Cancer risk, after all, is not experienced by our bodies as a statistic; we experience it within the context of our environment, access to care, psychosocial stressors and lived experience of uncertainty. Integrative or whole-person approaches to genetic counseling represent one path for bridging this gap, though these approaches are not yet consistently integrated into routine care.

Integrative oncology reflects a broader model of cancer risk and outcomes, recognizing that health is a product of the complex interplay between biological, behavioral, environmental and psychosocial factors. In practice, this may include attention to nutrition, physical activity, stress management and mind-body approaches alongside standard cancer care. These are generally understood as adjunctive to conventional medical care rather than a replacement. In this way, an integrative model both expands the boundaries of what is relevant to cancer risk and more accurately reflects how patients experience both risk and care. Although cancer, especially in the presence of genetic variants, is not always preventable, combining conventional and complementary therapies may help reduce risk. Research shows that limiting processed foods, excess sugar, sedentary behavior, alcohol intake and smoking has been associated with lower risks of cancer. Importantly, many of these recommendations are easier to discuss than they are to implement. Access to healthy food, safe environments for exercise, transportation, financial stability and time away from work all shape whether prevention strategies are realistically achievable for patients.

Integrative healthcare can also be beneficial for many patients with a cancer diagnosis undergoing active cancer treatment. Practices such as meditation and yoga have been shown to reduce anxiety, depression and fear of recurrence in breast cancer patients and may also improve quality of life, sleep and psychosocial adjustment. Massage therapy has been shown to be safe for cancer patients, reducing fatigue, pain, nausea and anxiety during treatment. Acupuncture has been recommended to reduce chemotherapy-induced nausea and vomiting. Mind-body integrative therapies reducing stress can potentially improve cancer treatment outcomes, as chronic stress can negatively affect immune function, inflammation and treatment adherence to chemotherapy and radiation.

Beyond the Risk Assessment

In cancer genetic counseling, a whole-person approach similarly requires broadening what is assessed or discussed during a patient encounter. In addition to gathering family history and assessing genetic risk, genetic counselors should also explore factors that could affect a patient’s ability to engage in recommended screening or prevention strategies. For example, a patient may fully understand recommendations for enhanced breast screening after learning they carry a pathogenic BRCA1 variant but still struggle to follow through because of transportation limitations, lack of paid time off, caregiving responsibilities or anxiety related to prior family cancer experiences. In these situations, the challenge is not simply understanding risk information but determining whether recommendations are realistically accessible and emotionally manageable within the context of a patient’s daily life. In our view, this is where whole-person care becomes especially relevant to cancer genetic counseling. Genetic counselors are often helping patients navigate uncertainty, prevention decisions and long-term risk management, making them uniquely positioned to explore the factors that may influence whether recommendations are realistic and sustainable. Attention to these areas can help genetic counselors tailor recommendations to the individual in a way that is both clinically appropriate and practically actionable.

Integrating these conversations into routine cancer genetic counseling may not always be straightforward. Providers and patients may struggle with believing in the validity of integrative, whole-person healthcare, as has been the history with many emerging areas of medicine. Genetic counselors need to stay up-to-date with both integrative and conventional oncology practices to ensure that they are delivering the most accurate information to patients. This also highlights the importance of collaboration in patient care. Collaboration among genetic counselors, oncologists and other healthcare providers delivers comprehensive support, ensures consistent communication and develops personalized care plans that address the diverse needs of patients through multiple modalities. For example, a genetic counselor can provide psychosocial support to a patient regarding decision-making and genetic testing results, but they should refer to a psychotherapist when it becomes outside of their scope. In this model, genetic counselors can serve as an entry point for broader conversations about care. Because genetic counselors frequently discuss risk, prevention and uncertainty, they may also be one of the first providers to identify barriers that could affect a patient’s ability to engage with care.

From Risk to Reality

Equity considerations are central throughout this process. Whole-person care, by definition, cannot be meaningfully integrated into proactive oncology if it is only available to those with the time, resources or support to engage with it. Structural barriers including differences in insurance coverage, transportation and healthcare navigation can limit who can benefit from supportive services, even where they are technically available. Without attention to these factors, efforts to expand whole-person care can unintentionally exacerbate existing disparities rather than address them. In turn, genetic counselors are well-positioned to recognize these gaps, help normalize conversations about them and connect patients with resources where possible.

As proactive oncology and genetic counseling continue to evolve, there is an opportunity to expand the role of genetic counseling beyond genetic risk assessment. The use of integrative health can make care more accessible and equitable for patients while enhancing patient empowerment and positively influencing perceptions of personal health. Expanded awareness, education and the ability of genetic counselors to implement integrative options can help improve patient access to whole-person care and contribute to more personalized approaches to cancer prevention and treatment. Cancer risk may be communicated through percentages, pedigrees and genetic test results, but it is ultimately experienced within the context of a person’s everyday life. As genetic counseling continues to evolve alongside proactive oncology care, whole-person approaches can help ensure that discussions about hereditary cancer risk remain grounded not only in genetics but also in the realities of patients’ lived experiences.

AI Disclosure: Generative AI (ChatGPT) was used to assist with organizing, merging and editing the authors’ original written assignments into a single cohesive submission. No new ideas or content were generated by AI; all concepts, analysis and final content reflect the authors’ own work.

References

1. Greenlee, H., DuPont-Reyes, M. J., Balneaves, L. G., Carlson, L. E., Cohen, M. R., Deng, G., Johnson, J. A., Mumber, M., Seely, D., Zick, S. M., Boyce, L. M., & Tripathy, D. (2017). Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians, 67(3), 194–232. https://doi.org/10.3322/caac.21397
2. Hall, D. L., Luberto, C. M., Philpotts, L. L., Song, R., Park, E. R., & Yeh, G. Y. (2018). Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis. Psycho-Oncology, 27(11), 2546–2558. https://doi.org/10.1002/pon.4757
3. Kushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark-Wahnefried, W., Bandera, E. V., Gapstur, S., Patel, A. V., Andrews, K., & Gansler, T. (2012). American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians, 62(1), 30–67. https://doi.org/10.3322/caac.20140
4. Latte-Naor, S., & Mao, J. J. (2019). Putting integrative oncology into practice: Concepts and approaches. Journal of Oncology Practice, 15(1), 7–14. https://doi.org/10.1200/JOP.18.00554
5. Mao, J. J., Pillai, G. G., Andrade, C. J., Ligibel, J. A., Basu, P., Cohen, L., Khan, I. A., Mustian, K. M., Puthiyedath, R., Dhillon, H. M., & others. (2022). Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA: A Cancer Journal for Clinicians, 72(2), 144–164. https://doi.org/10.3322/caac.21706
6. National Cancer Institute. (2022, October 21). Stress and cancer. https://www.cancer.gov/about-cancer/coping/feelings/stress-fact-sheet
7. National Center for Complementary and Integrative Health. (2020). Whole person health: What it is and why it’s important. https://www.nccih.nih.gov/health/whole-person-health-what-it-is-and-why-its-important

 

---